Cytochrome C and caspase-9 expression in Huntington's disease

NeuroMolecular Medicine

Volumn 1, Issue 3, 2002, Pages 183-195

  Kiechle, Tamara ^a,b   Dedeoglu, Alpaslan ^a,b   Kubilus, James ^a,b   Kowall, Neil W ^a,b   Beal, M Flint ^e   Friedlander, Robert M ^c,d   Hersch, Steven M ^e   Ferrante, Robert J ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Caspase; Cytochrome c; Huntington's; Immunocytochemistry; Western blot

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; CASP3 PROTEIN, HUMAN; CASP3 PROTEIN, MOUSE; CASP9 PROTEIN, HUMAN; CASP9 PROTEIN, MOUSE; CASPASE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; BRAIN NERVE CELL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; CYTOPLASM; DEGENERATIVE DISEASE; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME RELEASE; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WESTERN BLOTTING; AGE; ANIMAL; CELL COMPARTMENTALIZATION; CYTOSOL; DISEASE MODEL; ENZYMOLOGY; METABOLISM; MIDDLE AGED; MITOCHONDRION; NEOSTRIATUM; NERVE CELL; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; MURINAE; MUS MUSCULUS;

AGE FACTORS; AGED; ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 9; CASPASES; CELL COMPARTMENTATION; CYTOCHROME C GROUP; CYTOSOL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MITOCHONDRIA; NEOSTRIATUM; NEURONS;

EID: 0036048873     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:1:3:183     Document Type: Article

References (45)

1. Beal M. F. (2000) Energetics in the pathogenesis of neurodegenerative diseases. TINS 23, 298-304.
2. Buki A., Okonkwo D. O., Wang K. K. W., and Povlishock J. T. (2000) Cytochrome c release and caspase activation in traumatic axonal injury. J. Neurosci. 20, 2825-2834.
3. Cha J. H. (2000) Transcriptional dysregulation in Huntington's disease. TINS 23, 387-392.
4. Chen Q., Gong B., and Almasan A. (2000) Distinct stages of cytochrome c release from mitochondria: Evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis. Cell Death Differ. 7, 227-233.
5. Chen M., Ona V. O., Li M., Ferrante R. J., Fink K. B., Zhu S., et al. (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nature Med. 6, 797-801.
6. Chu Z. L., Pio F., Xie Z., Welsh K., Krajewska M., Krajewski S., Godzik A., and Reed J. C. (2001) A novel enhancer of the Apaf1 Apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J. Biol. Chem. 276, 9239-9245.
7. Cohen G. M. (1997) Caspases: The executioners of apoptosis. J. Biochem. 326, 1-16.
8. Desagher S. and Martinou J. C. (1998) Mitochondria as the central point of apoptosis. Trends Cell Biol. 10, 369-377.
9. Dragunow M., Faull R. L., Lawlor P., Beilharz E. J., Singleton K., Walker E. B., and Mee E. (1995) In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6, 1053-1057.
10. Du C., Fang M., Li Y., Li L., and Wang X. (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42.
11. Ferrante R. J., Andreassen O. A., Jenkins B. G., Dedeoglu A., Kuemmerle S., Kubilus J. K., et al. (2000) Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J. Neurosci. 20, 4389-4397.
12. Fujimura M., Morita-Fujimura Y., Muratami K., Kawase M., and Chan P. H. (1998) Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 18, 1239-1247.
13. Goldberg Y. P., Nicholson D. W., Rasper D. M., Kalchman M. A., Koide H. B., Graham R. K., et al. (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet 13, 442-449.
14. Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis. Science 281, 1309-1312.
15. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
16. Kowall N. W. and Ferrante R. J. (1998) Huntington's disease, in Neuropathology of Dementing Disorders (Markesbery M., ed.), Edward Arnold, London, UK, pp. 219-256.
17. Krajewska M., Wang H. G., Krajewski S., Zapata J. M., Shabaik A., Gascoyne R., and Reed J. C. (1997) Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res. 57, 1605-1613.
18. Kuemmerle S., Gutekunst C. A., Klein A. M., Li X. J., Li S. H., Beal M. F., et al. (1999) Huntington aggregates may not predict neuronal death in Huntington's disease. Ann. Neurol. 46, 842-849.
19. La Spada A. R., Paulson H. L., and Fischbeck K. H. (1994) Trinucleotide repeat expansion in neurological disease Ann. Neurol. 36, 814-822.
20. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., and Wang X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
21. Li S. H., Lam S., Cheng A. L., and Li X. J. (2000) Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis. Hum. Mol. Genet. 9, 2859-2867.
22. Liu X., Kim C. N., Yang J., Jemmerson R., and Wang X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157.
23. Mattson M. P. and Duan W. (1999) "Apoptotic" biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders. J. Neurosci. Res. 58, 152-166.
24. Miyashita T., Matsui J., Ohtsuka Y., Mami U., Fujishima S., Okamura-Oho Y., et al. (1999) Expression of extended polyglutamine sequentially activates initiator and effector caspases. Biochem. Biophys. Res. Commun. 257, 724-730.
25. Offen D., Elkon H., and Melamed E. (2000) Apoptosis as a general cell death pathway in neurodegenerative diseases. J. Neural Transm. Suppl. 58, 153-166.
26. Ona V. O., Li M., Vonsattel J. P., Andrews L. J., Khan S. Q., Chung W. M., et al. (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399, 263-267.
27. Pasinelli P., Houseweart M. K., Brown R. H., and Cleveland D. W. (2000) Caspase-1 and -3 are sequentially activated in motor neuron death in CuZn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 97, 13901-13906.
28. Plassart E. and Fontaine B. (1994) Genes with triplet repeats: a new class of mutations causing neurological diseases. Biomed. Pharmacother. 48, 191-197.
29. Petersen A., Mani K., and Brundin P. (1999) Recent advances on the pathogenesis of Huntington's disease. Exp. Neurol. 157, 1-18.
30. Portera-Cailliau C., Hedreen J. C., Price D. L., and Koliatsos V. E. (1995) Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787.
31. Qin Z. H., Wang Y., Kikly K. K., Sapp E., Kegel K. B., Aronin N., and DiFiglia M. (2001) Pro-caspase-8 is predominately localized in mitochondria and released into cytoplasm upon apoptotic stimulation. J. Biol. Chem. 276, 8079-8086.
32. Rey L., Maier and R.J. (1997) Cytochrome c terminal oxidase pathways of Azotobacter vinelandii: analysis of cytochrome c4 and c5 mutants and upregulation of cytochrome c-dependent pathways with N2 fixation. J. Bacteriol. 179, 7191-7196.
33. Rigamonti D., Bauer J. H., De-Fraja C., Conti L., Sipione S., Sciorati C., et al. (2000) Wild-type Huntingtin protects from apoptosis upstream of caspase-3. J. Neurosci. 20, 3705-3713.
34. Ross C. A. (1997) Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19, 1147-1150.
35. Roy S. and Nicholson D. W. (2000) Programmed cell-death regulation: basic mechanism and therapeutic opportunities. Mol. Med. Today 6, 264-266.
36. Sanchez I., Xu C. J., Juo P., Kazizaka A., Blenis J., and Yuan J. (1999) Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22, 623-633.
37. Sawa A., Wiegand G. W., Cooper J., Margolis R. L., Sharp A. H., Lawler J. F. Jr, et al. (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nature Med. 5,1194-1198.
38. Shimohama S. (2000) Apoptosis in Alzheimer's disease: an update. Apoptosis 5, 9-16.
39. Thornberry N. and Lazebnik Y. (1998) Caspases: enemies within. Science 281, 1312-1316.
40. Turmaine M., Raza A., Mahal A., Mangiarini L., Bates G. P., and Davies S. W. (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 97, 8093-8097.
41. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D., and Richardson E. P. Jr. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577.
42. Vukosavic S., Stefanis L., Jackson-Lewis V., Guegan C., Romero N., Chen C., et al. (2000) Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 20, 9119-9125.
43. Wellington C. L., Singaraja R., Ellerby L., Savill J., Roy S., Leavitt B., et al. (2000) Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 275, 19831-19838.
44. Wyllie A. H., Kerr J. E., and Currie A. R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
45. Zou H., Li Y., Liu X., and Wang X. (1999) An APAF-1/cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274, 11549-11556.